Hepion Pharmaceuticals Reports Positive Activity of CRV431 Against Coronavirus SARS-2 in Study Conducted by the National Institute of Allergy and Infectious Diseases
EDISON, NJ / ACCESSWIRE / September 17, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)(“Hepion”), a biopharmaceutical…
Modern Dental Group Announces 2026 Interim Results
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth
Nissin Foods Announces 2026 Interim Results
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities